Logo image of CBSM.PA

SCBSM (CBSM.PA) Stock Fundamental Analysis

EPA:CBSM - Euronext Paris - Matif - FR0006239109 - REIT - Currency: EUR

9  0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CBSM. CBSM was compared to 40 industry peers in the Diversified REITs industry. CBSM has only an average score on both its financial health and profitability. CBSM is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CBSM was profitable.
CBSM had a positive operating cash flow in the past year.
CBSM had positive earnings in each of the past 5 years.
In the past 5 years CBSM always reported a positive cash flow from operatings.
CBSM.PA Yearly Net Income VS EBIT VS OCF VS FCFCBSM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

1.2 Ratios

The Return On Assets of CBSM (0.07%) is worse than 70.00% of its industry peers.
CBSM's Return On Equity of 0.13% is on the low side compared to the rest of the industry. CBSM is outperformed by 70.00% of its industry peers.
The Return On Invested Capital of CBSM (2.70%) is worse than 70.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CBSM is in line with the industry average of 3.63%.
The 3 year average ROIC (2.45%) for CBSM is below the current ROIC(2.70%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.07%
ROE 0.13%
ROIC 2.7%
ROA(3y)2.98%
ROA(5y)3.77%
ROE(3y)6.05%
ROE(5y)7.76%
ROIC(3y)2.45%
ROIC(5y)2.41%
CBSM.PA Yearly ROA, ROE, ROICCBSM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

CBSM has a worse Profit Margin (1.52%) than 70.00% of its industry peers.
In the last couple of years the Profit Margin of CBSM has declined.
CBSM's Operating Margin of 76.80% is fine compared to the rest of the industry. CBSM outperforms 62.50% of its industry peers.
In the last couple of years the Operating Margin of CBSM has grown nicely.
CBSM has a Gross Margin (75.65%) which is in line with its industry peers.
In the last couple of years the Gross Margin of CBSM has grown nicely.
Industry RankSector Rank
OM 76.8%
PM (TTM) 1.52%
GM 75.65%
OM growth 3Y2.2%
OM growth 5Y4.35%
PM growth 3Y-74.65%
PM growth 5Y-58.24%
GM growth 3Y2.33%
GM growth 5Y3.97%
CBSM.PA Yearly Profit, Operating, Gross MarginsCBSM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50 100 150

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CBSM is destroying value.
CBSM has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CBSM has more shares outstanding
The debt/assets ratio for CBSM has been reduced compared to a year ago.
CBSM.PA Yearly Shares OutstandingCBSM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CBSM.PA Yearly Total Debt VS Total AssetsCBSM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of 1.24, we must say that CBSM is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CBSM (1.24) is better than 80.00% of its industry peers.
The Debt to FCF ratio of CBSM is 12.16, which is on the high side as it means it would take CBSM, 12.16 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CBSM (12.16) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.76 indicates that CBSM is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.76, CBSM perfoms like the industry average, outperforming 42.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 12.16
Altman-Z 1.24
ROIC/WACC0.56
WACC4.87%
CBSM.PA Yearly LT Debt VS Equity VS FCFCBSM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 3.07 indicates that CBSM has no problem at all paying its short term obligations.
CBSM's Current ratio of 3.07 is amongst the best of the industry. CBSM outperforms 97.50% of its industry peers.
A Quick Ratio of 3.07 indicates that CBSM has no problem at all paying its short term obligations.
CBSM has a Quick ratio of 3.07. This is amongst the best in the industry. CBSM outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.07
Quick Ratio 3.07
CBSM.PA Yearly Current Assets VS Current LiabilitesCBSM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

4

3. Growth

3.1 Past

CBSM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -96.45%.
The earnings per share for CBSM have been decreasing by -54.71% on average. This is quite bad
CBSM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.16%.
Measured over the past years, CBSM shows a small growth in Revenue. The Revenue has been growing by 6.51% on average per year.
EPS 1Y (TTM)-96.45%
EPS 3Y-71.89%
EPS 5Y-54.71%
EPS Q2Q%405.2%
Revenue 1Y (TTM)8.16%
Revenue growth 3Y7.97%
Revenue growth 5Y6.51%
Sales Q2Q%8.4%

3.2 Future

CBSM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 239.41% yearly.
Based on estimates for the next years, CBSM will show a small growth in Revenue. The Revenue will grow by 0.32% on average per year.
EPS Next Y3300%
EPS Next 2Y511.56%
EPS Next 3Y239.41%
EPS Next 5YN/A
Revenue Next Year-9.89%
Revenue Next 2Y-0.7%
Revenue Next 3Y0.32%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CBSM.PA Yearly Revenue VS EstimatesCBSM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M
CBSM.PA Yearly EPS VS EstimatesCBSM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2025 2026 2027 0.2 0.4 0.6 0.8

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 300.00, which means the current valuation is very expensive for CBSM.
Compared to the rest of the industry, the Price/Earnings ratio of CBSM indicates a slightly more expensive valuation: CBSM is more expensive than 72.50% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.98, CBSM is valued quite expensively.
A Price/Forward Earnings ratio of 11.03 indicates a reasonable valuation of CBSM.
CBSM's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 21.49. CBSM is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 300
Fwd PE 11.03
CBSM.PA Price Earnings VS Forward Price EarningsCBSM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CBSM is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, CBSM is valued cheaper than 90.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.6
EV/EBITDA 17.47
CBSM.PA Per share dataCBSM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

CBSM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CBSM's earnings are expected to grow with 239.41% in the coming years.
PEG (NY)0.09
PEG (5Y)N/A
EPS Next 2Y511.56%
EPS Next 3Y239.41%

0

5. Dividend

5.1 Amount

CBSM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SCBSM

EPA:CBSM (6/23/2025, 7:00:00 PM)

9

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)03-27 2025-03-27
Earnings (Next)09-29 2025-09-29
Inst Owners0.08%
Inst Owner ChangeN/A
Ins Owners52.35%
Ins Owner ChangeN/A
Market Cap123.57M
Analysts82.86
Price Target11.12 (23.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 300
Fwd PE 11.03
P/S 5.72
P/FCF 7.6
P/OCF 7.6
P/B 0.49
P/tB 0.49
EV/EBITDA 17.47
EPS(TTM)0.03
EY0.33%
EPS(NY)0.82
Fwd EY9.07%
FCF(TTM)1.18
FCFY13.17%
OCF(TTM)1.18
OCFY13.17%
SpS1.57
BVpS18.45
TBVpS18.45
PEG (NY)0.09
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.07%
ROE 0.13%
ROCE 3.68%
ROIC 2.7%
ROICexc 2.9%
ROICexgc 2.9%
OM 76.8%
PM (TTM) 1.52%
GM 75.65%
FCFM 75.24%
ROA(3y)2.98%
ROA(5y)3.77%
ROE(3y)6.05%
ROE(5y)7.76%
ROIC(3y)2.45%
ROIC(5y)2.41%
ROICexc(3y)2.67%
ROICexc(5y)2.6%
ROICexgc(3y)2.67%
ROICexgc(5y)2.6%
ROCE(3y)3.33%
ROCE(5y)3.29%
ROICexcg growth 3Y5.51%
ROICexcg growth 5Y3.74%
ROICexc growth 3Y5.51%
ROICexc growth 5Y3.74%
OM growth 3Y2.2%
OM growth 5Y4.35%
PM growth 3Y-74.65%
PM growth 5Y-58.24%
GM growth 3Y2.33%
GM growth 5Y3.97%
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 12.16
Debt/EBITDA 11.65
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.94
Cash Conversion 97.94%
Profit Quality 4959.76%
Current Ratio 3.07
Quick Ratio 3.07
Altman-Z 1.24
F-Score7
WACC4.87%
ROIC/WACC0.56
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)1716.66%
Profit Quality(5y)1054.82%
High Growth Momentum
Growth
EPS 1Y (TTM)-96.45%
EPS 3Y-71.89%
EPS 5Y-54.71%
EPS Q2Q%405.2%
EPS Next Y3300%
EPS Next 2Y511.56%
EPS Next 3Y239.41%
EPS Next 5YN/A
Revenue 1Y (TTM)8.16%
Revenue growth 3Y7.97%
Revenue growth 5Y6.51%
Sales Q2Q%8.4%
Revenue Next Year-9.89%
Revenue Next 2Y-0.7%
Revenue Next 3Y0.32%
Revenue Next 5YN/A
EBIT growth 1Y10.84%
EBIT growth 3Y10.34%
EBIT growth 5Y11.14%
EBIT Next Year2.59%
EBIT Next 3Y4.54%
EBIT Next 5YN/A
FCF growth 1Y10.82%
FCF growth 3Y5.08%
FCF growth 5Y22.16%
OCF growth 1Y10.82%
OCF growth 3Y5.08%
OCF growth 5Y22.16%